2023 FDA approvals: unprecedented volume at moderate value

Nat Rev Drug Discov. 2024 Feb;23(2):98. doi: 10.1038/d41573-024-00011-9.
No abstract available

Publication types

  • News

MeSH terms

  • Antineoplastic Agents*
  • Drug Approval
  • Humans
  • United States
  • United States Food and Drug Administration

Substances

  • Antineoplastic Agents